Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Financial plan Cordial Home Redesigns That Add Worth - 2Astronomers detect black hole blasting winds at incredible speeds
- 3Treasure trove found in Egyptian tomb solves ancient mystery
- 4All that You Really want to Be familiar with Dental Inserts Facilities
- 5Tech Patterns: Contraptions That Will Shape What's in store
- Pick Your Top Method for starting the Morning
- Judge approves Purdue Pharma’s new $7B opioid settlement with the Sacklers
- Nature: 10 High priority Setting up camp Spots In Europe
- 6 Fledgling Cameras for 2024: Ideal for New Photographic artists
- Meet the Stars of the Feline World: Well known Pet Feline Varieties
- Nestlé recalls infant formula in 49 countries. See list.
- New trailer for 'Bridgerton' Season 4 teases Benedict's love story: Watch it here
- Find the Advantages of Positive Nurturing: Supporting Cheerful and Sound Kids
- The most effective method to Promoter for Cellular breakdown in the lungs Mindfulness in Your People group
